KLRA

Kailera Therapeutics, Inc. Common Stock

NASDAQ: KLRA · HEALTHCARE · BIOTECHNOLOGY

$25.15

+0.60% today

Updated 2026-05-01

Market cap

$3.21B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.26

Dividend yield

—

52W range

$16 – $28

Volume

1.8M

Market cap

$3.21B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.26

Dividend yield

—

52W range

$16 – $28

Volume

1.8M

Kailera Therapeutics, Inc. Common Stock (KLRA) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price

$25.15

12-Month target

—

2030 Target

—

Intrinsic (DCF)

—

Financial forecast

Metric	2025
Revenue	$0.0B
EPS	—

CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.